What is the Return on Assets (ROA) of Nicox this year?
The Return on Assets (ROA) of Nicox is -0.39 undefined this year.
Nicox ROA 2024
Nicox ROA
-0.39
Ticker
ALCOX.PA
ISIN
FR0013018124
WKN
A143G8
In 2024, Nicox's return on assets (ROA) was -0.39, a 32.28% increase from the -0.3 ROA in the previous year.
Nicox Aktienanalyse
What does Nicox do?
Nicox SA is a French pharmaceutical company specializing in the development and commercialization of innovative therapy systems for eye diseases. It was founded in 1996 as a spin-off of Nestlé's research activities in the field of ophthalmology. The company's business model is based on the development of drugs based on nitric oxide (NO), a gaseous molecule that plays an important role in regulating blood flow and inflammation processes in the human body. Nicox SA's technology allows for the targeted release of NO donors in specific areas of the eye to reduce disease-related inflammation and damage. This provides a promising alternative to conventional therapies for a range of eye diseases. Nicox SA is divided into three business areas: Ophthalmology, Diagnostics, and Contracts. In the Ophthalmology segment, the company focuses on the development of drugs for the treatment of glaucoma, dry eye, and other eye diseases. Important products in this area include Vyzulta, a combination of an NO donor and a glaucoma drug, as well as NCX 470, an NO donor for the treatment of glaucoma. In addition, the company is working on the development of NCX 4251, an NO donor for the treatment of blepharitis, an inflammation of the eyelids. In the Diagnostics segment, Nicox SA offers innovative diagnostic tests for ophthalmology based on tear fluid analysis. These tests enable ophthalmologists to diagnose and monitor certain eye diseases more quickly and accurately. Key products in this area include AdenoPlus, a rapid test for diagnosing adenovirus conjunctivitis, and ClearSight, a test for monitoring glaucoma patients. The Contracts segment offers customized clinical research services for customers in the pharmaceutical industry. This segment is an important part of Nicox SA's strategy to generate additional revenue and finance the development of new therapies. Overall, Nicox SA has a strong pipeline of new therapies and diagnostic tests that allow the company to consolidate its position as a leading provider of eye medications. The company works closely with its industry and academic research partners to develop and bring innovative therapies to the market. In summary, Nicox SA is an innovative and rapidly growing company focusing on the development and commercialization of therapies for eye diseases. The company has a strong pipeline of new products and services and collaborates closely with its partners to strengthen its position in the industry. Nicox ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Nicox's Return on Assets (ROA)
Nicox's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Nicox's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Nicox's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Nicox’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Nicox stock
What was the ROA of Nicox compared to the previous year?
The ROA of Nicox has increased by 32.28% compared to the previous year.
What consequences do high ROA have for investors of Nicox?
A high ROA is advantageous for investors of Nicox, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Nicox?
A low ROA can be unfavorable for investors of Nicox as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Nicox affect the company?
An increase in ROA of Nicox can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Nicox impact the company?
A reduction in the ROA of Nicox can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Nicox?
Some factors that can influence the ROA of Nicox include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Nicox important for investors?
The ROA of Nicox is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Nicox take to improve ROA?
To improve ROA, Nicox can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Nicox pay?
Over the past 12 months, Nicox paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nicox is expected to pay a dividend of 0 EUR.
What is the dividend yield of Nicox?
The current dividend yield of Nicox is .
When does Nicox pay dividends?
Nicox pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Nicox?
Nicox paid dividends every year for the past 0 years.
What is the dividend of Nicox?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Nicox located?
Nicox is assigned to the 'Health' sector.
Wann musste ich die Aktien von Nicox kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Nicox from 10/12/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/12/2024.
When did Nicox pay the last dividend?
The last dividend was paid out on 10/12/2024.
What was the dividend of Nicox in the year 2023?
In the year 2023, Nicox distributed 0 EUR as dividends.
In which currency does Nicox pay out the dividend?
The dividends of Nicox are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Nicox stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Nicox
Our stock analysis for Nicox Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nicox Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.